Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

538 ARTÍCULOS , VIENDO DEL 226 AL 240

Free water improves detection of changes in the substantia nigra in parkinsonism: A multisite study

Ofori E, Krismer F, Burciu RG, Pasternak O, McCracken JL, Lewis MM, Du G, McFarland NR, Okun MS, Poewe W, Mueller C, Gizewski ER, Schocke M, Kremser C, Li H, Huang X, Seppi K, Vaillancourt DE.

Mov Disord. 2017 Oct;32(10):1457-1464. doi: 10.1002/mds.27100. Epub 2017 Jul 17.

Parkinson's Disease and Its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies

Brucker BM, Kalra S.

Urol Clin North Am. 2017 Aug;44(3):415-428. doi: 10.1016/j.ucl.2017.04.008.

A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations

Mollenhauer B, Batrla R, El-Agnaf O, Galasko DR, Lashuel HA, Merchant KM, Shaw LM, Selkoe DJ, Umek R, Vanderstichele H, Zetterberg H, Zhang J, Caspell-Garcia C, Coffey C, Hutten SJ, Frasier M, Taylor P; Investigating Synuclein Consortium of the Michael J. Fox Foundation for Parkinson's Research.

Mov Disord. 2017 Aug;32(8):1117-1130. doi: 10.1002/mds.27090. Epub 2017 Jul 22.

Novel Eye Movement Disorders in Whipple's Disease-Staircase Horizontal Saccades, Gaze-Evoked Nystagmus, and Esotropia

Shaikh AG, Ghasia FF.

Front Neurol. 2017 Jul 11;8:321. doi: 10.3389/fneur.2017.00321. eCollection 2017.

Head trauma and Parkinson's disease: results from an Italian case-control study

Nicoletti A, Vasta R, Mostile G, Nicoletti G, Arabia G, Iliceto G, Lamberti P, Marconi R, Morgante L, Barone P, Quattrone A, Zappia M.

Neurol Sci. 2017 Oct;38(10):1835-1839. doi: 10.1007/s10072-017-3076-5. Epub 2017 Jul 26.

Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease

West AB.

Exp Neurol. 2017 Dec;298(Pt B):236-245. doi: 10.1016/j.expneurol.2017.07.019. Epub 2017 Jul 29.

Eyelid Dysfunction in Neurodegenerative, Neurogenetic, and Neurometabolic Disease

Hamedani AG, Gold DR.

Front Neurol. 2017 Jul 18;8:329. doi: 10.3389/fneur.2017.00329. eCollection 2017.

Premotor Diagnosis of Parkinson's Disease

Reichmann H.

Neurosci Bull. 2017 Oct;33(5):526-534. doi: 10.1007/s12264-017-0159-5. Epub 2017 Aug 3.

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T.

Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016/S0140-6736(17)31585-4. Epub 2017 Aug 3.

Critical appraisal of clinical trials in multiple system atrophy: Toward better quality

Castro Caldas A, Levin J, Djaldetti R, Rascol O, Wenning G, Ferreira JJ; Movement Disorders Society MSA Study Group.

Mov Disord. 2017 Oct;32(10):1356-1364. doi: 10.1002/mds.27080. Epub 2017 Aug 7.

Biomarkers of Nonmotor Symptoms in Parkinson's Disease

Konno T, Al-Shaikh RH, Deutschländer AB, Uitti RJ.

Int Rev Neurobiol. 2017;133:259-289. doi: 10.1016/bs.irn.2017.05.020. Epub 2017 Jun 27.

Understanding and Treating Pain Syndromes in Parkinson's Disease

Gandolfi M, Geroin C, Antonini A, Smania N, Tinazzi M.

Int Rev Neurobiol. 2017;134:827-858. doi: 10.1016/bs.irn.2017.05.013. Epub 2017 Jul 3.

Acute Presentation of Nonmotor Symptoms in Parkinson's Disease

Kwei K, Frucht S.

Int Rev Neurobiol. 2017;134:973-986. doi: 10.1016/bs.irn.2017.06.002. Epub 2017 Jul 10.

La belle indifférence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder

van Meerkerk-Aanen PJ, de Vroege L, Khasho D, Foruz A, van Asseldonk JT, van der Feltz-Cornelis CM.

Neuropsychiatr Dis Treat. 2017 Aug 2;13:2057-2067. doi: 10.2147/NDT.S130475. eCollection 2017.

Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease

Picillo M, Barone P, Pellecchia MT.

Mov Disord Clin Pract. 2017 Aug 21;4(5):652-662. doi: 10.1002/mdc3.12521. eCollection 2017 Sep-Oct.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias